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Abstract Eukaryotic 70 kDa heat shock proteins (Hsp70s) are
localized in various cellular compartments and exhibit functions
such as protein translocation across membranes, protein folding
and assembly. Here we demonstrate that the constitutively
expressed members of the yeast cytoplasmic Ssa subfamily,
Ssa1/2p, are involved in the transport of the vacuolar hydrolase
aminopeptidase 1 from the cytoplasm into the vacuole. The Ssap
family members displayed overlapping functions in the transport
of aminopeptidase 1. In SSAI and SSAII deletion mutants the
precursor of aminopeptidase 1 accumulated in a dodecameric
complex that is packaged in prevacuolar transport vesicles. Ssa1/
2p was prominently localized to the vacuolar membrane,
consistent with the role we propose for Ssa proteins in the fusion
of transport vesicles with the vacuolar membrane.
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1. Introduction
Cytosolic members of the 70 kDa heat shock protein family
(Hsp70) facilitate import of precursor proteins into chloro-
plasts, into the endoplasmic reticulum (ER) and into mito-
chondria [1^4]. They are also involved in the transport of
proteins into peroxisomes and nuclei [5,6]. Cytosolic Hsp70s
also appear to be involved in the transport of a certain sub-
class of cytoplasmic proteins into lysosomes of mammalian
cells [7]. However, the precise function of Hsp70s in these
import pathways is not known.
Other members of the Hsp70 family are located in the lu-
men of chloroplasts, ER, lysosomes and mitochondria. Be-
sides their role in protein folding they are also involved in
the transport of precursor proteins across the membranes of
ER, chloroplasts and mitochondria [4,8^14].
Six members of the Hsp70 family are present in the cyto-
plasm of Saccharomyces cerevisiae (Ssa1p, Ssa2p, Ssa3p,
Ssa4p, Ssb1p, Ssb2p [15]). Ssa proteins (Ssap) are known to be
involved in protein import into organelles and in the assembly
of oligomeric protein complexes, whereas the Ssb proteins are
involved in protein biosynthesis. Ssa1p and Ssa2p are consti-
tutively expressed, Ssa3p and Ssa4p are expressed under stress
conditions.
In S. cerevisiae soluble resident vacuolar proteins are trans-
ported to the vacuole by at least two di¡erent pathways:
through the classical secretory pathway as well as through
the direct cytoplasm to vacuole transport pathway. Most of
the vacuolar resident proteins, such as carboxypeptidase Y
(CPY) and proteinase A, ¢rst enter the ER and travel through
the Golgi from where they are transported into vesicles and to
the vacuole [16^18]. K-Mannosidase and aminopeptidase 1
(Ape1p) are examples of resident vacuolar proteins which
are transported to the vacuole directly from the cytoplasm
[19,20].
Aminopeptidase 1 is synthesized as a 61 kDa cytoplasmic
precursor protein pApe1p [21]. The maturation of pApe1p is a
two-step process occurring in the vacuole. The 61 kDa pre-
cursor is sequentially converted into a 55 kDa intermediate by
proteinase A and ¢nally into the 50 kDa mature form by
proteinase B [22]. The active enzyme is a dodecameric com-
plex with a molecular mass of approximately 600 kDa [23].
Transport of the precursor protein to the vacuole occurs in-
dependently of the secretory pathway. Several independent
pieces of evidence support this conclusion: pApe1p transport
is not a¡ected in mutants of the early secretory and Golgi to
vacuole pathway. Overexpression of vacuolar hydrolases leads
to their secretion, whereas overexpressed Ape1p is not se-
creted [20]. pApe1p does not contain an ER signal sequence
[24]. The targeting signal resembles much more a mitochon-
drial targeting signal [25,26]. pApe1p has a half-life of matu-
ration of 45 min compared to a half-life of approximately
6 min for other vacuolar hydrolases transported via the secre-
tory pathway [20].
Two di¡erent mechanisms might be operative in pApe1p
transport [22,27,28]. A translocation mechanism and a
vesicle-mediated process have been proposed. Segu|¤-Real
and coworkers [22] showed that a modi¢ed pApe1p carrying
a myc tag at the C-terminus got stuck in the vacuolar mem-
brane. The vacuolar targeting signal of this stuck import in-
termediate was processed to the intermediate form by protein-
ase A. The myc epitope was sensitive to externally added
proteinase in the absence of a detergent, suggesting that the
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N-terminus of the stuck pApe1p is in the vacuolar lumen
while the C-terminus is in the cytoplasm. Analysis of cyto-
plasm to vacuole targeting mutants [27^29] demonstrates a
vesicle-based transport mechanism. The observation that the
precursor of pApe1p assembles with a half-life of 2 min in the
cytoplasm indicates that pApe1p enters the cytoplasm to vac-
uole (Cvt) vesicles as a pre-dodecamer. Cvt vesicles have a
double membrane supporting the idea of an autophagocyto-
sis-like mechanism. The genetic and phenotypic overlap be-
tween autophagy and the Cvt targeting pathway suggests that
the pApe1p transport pathway uses some components of the
autophagocytosis machinery.
It has been shown that proteins entering mitochondria or
ER are partially unfolded [1,30^32]. In contrast, conforma-
tional studies of peroxisomal proteins have shown that they
can enter the peroxisomal matrix in a fully folded state [33]. In
fact, large pre-assembled oligomeric complexes can be im-
ported into the peroxisomal lumen. Studies indicate that
pApe1p enters the vacuole as a fully assembled pre-dodecamer
[34]. Pulse chase experiments suggested that oligomerization is
an early step in pApe1p import. Mutants in the Cvt pathway
and propeptide deletion mutants are defective only in import
and not in oligomerization suggesting that the propeptide is
responsible for vacuolar delivery [25,26].
The N-terminal cleavable propeptide of pApe1p is 45 amino
acids long and forms two K-helices separated by a L-turn. The
presequence of 17 residues folds into an amphipathic K-helix
similar to the mitochondrial targeting signals [20,25,26]. Using
NMR spectroscopy it has been shown that mutations which
destabilize the helix inhibit the transport of pApe1p [26].
The similarity of mitochondrial and vacuolar targeting se-
quences suggested that similar targeting factors are involved
in the transport of proteins in both transport pathways.
Therefore, we investigated the function of the cytoplasmic
Hsp70 chaperones of the Ssap family in the transport of
pApe1p into the vacuole.
2. Materials and methods
2.1. Strains and media
S. cerevisiae strains used in this study were: MW109 (referred to as
wild-type in this study): MATa his3 leu2 lys2 vtrp1 ura3 ; JN114
(referred to as vssaI in this study): MATa his3-11,3-15 leu2-3,2-112
ura3-52 trp1-v1 lys2 ssa1: :HIS3 ; JN115 (referred to as vssaII in this
study): MATa his3-11,3-15 leu2-3,2-112 ura3-52 trp1-v1 lys2
ssa2: :URA3 ; MW123 (referred to as vssaI/II in this study): MATa
his3 leu2 lys2 vtrp1 ura3 ssa1: :HIS3 ssa2: :LEU2. The above de-
scribed strains are described by Werner-Washburne et al. [15].
MH50 (referred to as vssaII+pSSAI in this study): MATa his3-
11,3-15 leu2-3,2-112 ura3-52 trp1-v1 lys2 ssa2: :URA3 Ycplac111-
SSAI ; MH51 (referred to as vssaII+pSSAII in this study): MATa
his3-11,3-15 leu2-3,2-112 ura3-52 trp1-v1 lys2 ssa2: :URA3 Yc-
plac111-SSAII ; MH52 (referred to as vssaI+pSSAII in this study):
MATa his3-11,3-15 leu2-3,2-112 ura3-52 trp1-v1 lys2 ssa1: :HIS3 Yc-
plac111-SSAII.
Yeast cells were grown in YPD (1% yeast extract, 2% peptone, 2%
glucose), SD-N (0.17% yeast nitrogen base without amino acids, 2%
glucose; [43]), or SD (0.67% yeast nitrogen base without amino acids,
2% glucose). The powdered media were purchased from Gibco-BRL.
2.2. Protein extraction
Cells were grown to the mid-exponential phase in YPD and pelleted
at 4500Ug for 5 min. The cell pellet was resuspended in Tris^SO4/
DTT bu¡er (0.1 M Tris^SO4 pH 9.4, 10 mM dithiothreitol) at a ¢nal
concentration of 10 OD600 cells/ml. The cells were incubated at room
temperature for 20 min, again pelleted at 1500Ug for 5 min and
resuspended in spheroplasting bu¡er (1.2 M sorbitol, 50 mM Tris^
HCl pH 7.4, lyticase 2.5 Wl/10 OD600 (Boehringer, Mannheim)) and
incubated at 30‡C for 30 min with slow shaking. Spheroplasts were
pelleted at 4500Ug for 3 min and resuspended in 700 Wl of 0.1 M
sodium phosphate pH 7.4. Spheroplasts were broken using glass
beads. Samples were vortexed at maximum speed three times, 2 min
each. Unbroken spheroplasts and glass beads were pelleted in a micro-
fuge. The supernatant was collected and the protein content estimated
using the Bio-Rad reagent (Bio-Rad, Hercules, CA). 70 Wg of total
protein was precipitated, resuspended in Laemmli bu¡er and sepa-
rated by 10% SDS^PAGE.
2.3. Glycerol density gradients
Cell extracts were prepared as described above. 20^50% glycerol
step gradients (20%, 30%, 40% and 50% glycerol solutions in 20 mM
K-PIPES pH 6.8) were prepared as described by Scott et al. [37].
1.2 mg of protein was loaded onto each gradient and centrifuged at
55 000 rpm for 4 h at 15‡C using the TLS-55 rotor in the Beckmann
table-top ultracentrifuge. Following centrifugation, 10 fractions were
collected from each gradient, the proteins were precipitated in tri-
chloroacetic acid (TCA), resuspended in Laemmli bu¡er and sepa-
rated by 10% SDS^PAGE.
2.4. Isolation of vacuoles
Cell fractionation was essentially done as described by Scott et al.
[37] with the following modi¢cations. Cells were grown in YPD at
30‡C to an OD600 of 0.8^1.0. Cells were harvested by a 5 min spin at
4500Ug, incubated for 20 min at 30‡C with 100 mM Tris^SO4 pH
9.4, 10 mM DTT and pelleted for 5 min at 4500Ug. The cell pellet
was resuspended in spheroplasting bu¡er (1.2 M sorbitol, 50 mM
Tris^HCl pH 7.4, 0.5 mg zymolyase 20T/50 OD600 (Seikagaku, To-
kyo) and incubated for 30 min at 30‡C. Spheroplasts were pelleted for
2 min at 4‡C at 500Ug. Spheroplasts were lysed with water and mixed
with 60% Optiprep to give a ¢nal concentration of 37% in 3 ml 10 mM
K-PIPES pH 6.8. The suspension was overlaid with 2 ml of 30, 25, 19,
and 0% fractions and was centrifuged at 25 000 rpm for 4 h at 4‡C in
a SW40 (Beckman). For Ficoll gradients the equivalent of 300 OD600
of cells was used per gradient. The spheroplasting was done with
zymolyase 20T (Seikagaku Corporation, Japan) at a concentration
of 0.5 mg/50 OD600 of cells. The spheroplasts were lysed with water
and mixed with 40% Ficoll, sorbitol (2.5 M stock) and K-PIPES pH
6.8 (100 mM stock) were added to ¢nal concentrations of 12%,
200 mM and 10 mM respectively. The resuspension was overlaid
with 2 ml of 8% Ficoll, 2 ml 4% Ficoll and 1 ml of 200 mM sorbitol,
10 mM K-PIPES pH 6.8. The gradient was centrifuged at 30 000 rpm
for 90 min at 4‡C in the Beckmann SW40 rotor. Interphases were
collected and analyzed by Western blotting. The protein content was
estimated using the Bio-Rad protein assay reagent. A 500 ml culture
yields approximately 350 Wg vacuolar protein.
2.5. Protease treatment
Cells were spheroplasted and di¡erentially lysed as described above.
Proteinase K or proteinase K together with Triton X-100 was added
to a ¢nal concentration of 50 Wg/ml or 0.2%. The samples were in-
cubated on ice for 30 min, phenylmethylsulfonyl £uoride was added to
a ¢nal concentration of 1 mM and the reaction was further incubated
for 10 min on ice. The proteins were TCA-precipitated, resuspended
in Laemmli bu¡er and separated by 10% SDS^PAGE.
2.6. Immuno£uorescence
Cells were grown to exponential phase in YPUAD at 25‡C, spun
down for 2 min at 2500Ug and resuspended in ¢xative (3.5% PFA/
10% sorbitol/PBS). Cells were ¢xed for 2 h at room temperature.
Immuno£uorescence was then performed as described [35]. After per-
meabilization of the cell wall with lyticase cells were quenched with
PBS/10% sorbitol/1% BSA and then incubated with antiserum recog-
nizing both Ssa1p and Ssa2p diluted 1:4000 in quenching solution for
1 h. Secondary Cy3-conjugated goat anti-rabbit antibodies were ap-
plied for 30 min.
2.7. Molecular biology
Ssa2p was reintroduced into JN115 and JN114 by transforming the
strains with a derivative of the plasmid Ycplac111 containing a 5.5 kb
genomic clone of SSAII. Ssa1p was reintroduced into JN114 and
JN115 by transforming the strains with a derivative of the plasmid
Ycplac111 containing a 6.5 kb genomic clone of SSAI.
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3. Results
3.1. Ssa proteins are involved in the transport of
aminopeptidase 1 from the cytoplasm into the vacuole
To test whether Ssa proteins are involved in the transport
of pApe1p from the cytoplasm into the vacuole we used yeast
strains in which the constitutively expressed Ssa1p, Ssa2p, or
both are not present [15]. The steady-state level of the precur-
sor and the mature form of Ape1p in these strains was deter-
mined by Western blotting. As the maturation of pApe1p
occurs only inside the vacuole, the presence of the mature
protein can be used as an indicator for the vacuolar delivery
of the precursor [20].
Wild-type (wt) yeast cells and SSA deletion mutants were
grown to mid-exponential phase in rich medium to prevent
upregulation of autophagocytosis. Western blot analysis was
done using a polyclonal anti-Ape1p antibody. In the wt strain
only the mature form of Ape1p (mApe1p) with a molecular
weight of 50 kDa was detected (Fig. 1A, lane 1). In the strains
Fig. 1. Accumulation of Ape1p precursor in vssa mutants. A: Cell
extracts prepared from wt, vssaI, vssaII, and vssaI/II strains grown
in YPD at 30‡C (lanes 1^4) or at 35‡C (lanes 5^8). B: Cell extracts
prepared from wt, vssaII, and vssaII cells carrying a single copy
plasmid containing the SSAII gene under the control of its endoge-
nous promoter (vssaII+pSSAII). C: Cell extracts prepared from
vssaI and vssaI cells carrying a single copy plasmid containing the
SSAII gene under the control of its endogenous promoter
(vssaI+pSSAII). Western blot analyses were done using anti-Ape1p
antibodies, or anti-hexokinase antibodies. The hexokinase control
was used as an internal control.
Fig. 2. Expression of Ssa3/4p in vssa mutants. A: Cell extracts were
prepared from wt, vssaI, vssaII, and vssaI/II strains grown in YPD
at 30‡C. B: Cell extracts were prepared from wt, vssaII, and vssaI/
II strains grown at an elevated temperature of 35‡C. Western blot
analyses were done using anti-Ssa3/4p antibodies or anti-hexokinase
antibodies. *Degradation products of Ssa3/4p. C: Quanti¢cation of
Ssa3/4p expression under growth conditions which bypass the Ssa1/
2p requirement for pApe1p transport (n.d., not detectable).
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missing Ssa1p (Fig. 1A, lane 2) or Ssa2p (Fig. 1A, lane 3) an
accumulation of the 61 kDa precursor form (pApe1p) was
observed. In mutants missing both chaperones (Fig. 1A,
lane 4), no increase in the accumulation of the precursor
was seen compared with the single deletion strains.
Expression of the Ssa2p from a single copy plasmid, con-
taining the SSAII gene under its own promoter, is able to
rescue the mutant phenotype in the vssaII strain (Fig. 1B,
compare lanes 1 and 3) as well as in the vssaI strain (Fig.
1C, compare lanes 1 and 3). Vice versa Ssa1p rescues the
mutant phenotype in the vssaII strain (Fig. 1C, compare lanes
4 and 6) as well as in the vssaI strain (data not shown), clearly
demonstrating overlapping functions of Ssa1p and Ssa2p.
The loss of one or more members of the Ssap family can be
compensated by overexpressing other family members [15].
Western blot analysis of cell extracts from wt and mutant
strains with an antibody that recognizes Ssa3p and Ssa4p
shows under steady-state conditions an overexpression of
Ssa3/4p, in the vssaII strain (Fig. 2A, lane 3) and to a higher
degree in the vssaI/II strain (Fig. 2A, lane 4). As in unstressed
cells about 30% of the Ssa proteins are Ssa1p (the other 70%
are Ssa2p), we barely observed an overexpression of Ssa3/4p
in the vssaI mutant (Fig. 2A, lane 2). Ssa3p and Ssa4p ap-
parently compensate for the loss of Ssa1/2p function in the
transport of pApe1p.
This conclusion is supported by an experiment in which wt
yeast cells and SSA deletion mutants were grown at 30‡C and
shifted to an elevated temperature of 35‡C for 1 h (Fig. 1A,
lanes 5^8). In the vssaI/II strain no accumulation of the pre-
cursor of Ape1p was seen (Fig. 1A, lane 8). Under these heat
shock conditions Ssa3/4p are overexpressed in the vssaII mu-
tant (Fig. 2B, lane 2). However, Ssa3/4p overexpression is
higher in the vssaI/II strain (Fig. 2B, lane 3). These results
suggest that under stress conditions, induced either by dele-
tion of constitutively expressed Ssa proteins or by an elevated
temperature, Ssa3p and Ssa4p are expressed at levels which
can fully complement lack of Ssa1p and Ssa2p function in the
transport of pApe1p into the vacuole.
mApe1p and pApe1p expression levels were found to be
reduced at 30‡C in vssa strains (Fig. 1A). Ape1p expression
is upregulated under heat stress at 35‡C (Fig. 1A), which is
known to elevate the expression levels of several vacuolar
proteins [36]. At 35‡C Ape1p expression increased in vssa
strains to wt expression levels and therefore we assume that
reduced expression levels of Ape1p at 30‡C in vssa strains
might be an indirect e¡ect of Ssap de¢ciency. Deletion of
the vacuolar proteinase A in the vssaI strain did not increase
the amount of Ape1p (not shown), excluding increased vacuo-
lar turnover of Ape1p due to misfolding. We tested for direct
interaction between Ssa1/2p and pApe1p by chemical cross-
linking, puri¢cation of crosslinked complexes by anti-Ssa1/2p
immunoa⁄nity columns followed by Western blot analysis,
but we were not able to identify crosslinked products. This
negative result does not exclude the possibility of a pApe1p^
Ssap interaction prior to packaging of pApe1p into Cvt
vesicles (see also Section 3.2).
Fig. 3. The accumulated precursor of Ape1p forms a dodecamer.
Cell extracts were prepared from wt and vssaII cells. Proteins were
separated according to their molecular weight on a glycerol density
gradient, precipitated, separated by SDS^PAGE and immunoblotted
with an antibody against Ape1p. Molecular weight standards indi-
cated are aldolase (158 kDa), catalase (240 kDa), ferritin (450 kDa)
and thyroglobulin (669 kDa). pApe1p: precursor Ape1p; mApe1p:
mature form of Ape1p; MW: molecular weight.
Fig. 4. The precursor of Ape1p accumulates in a prevacuolar com-
partment. A: vssaII cells were spheroplasted, di¡erentially lysed and
protease-treated with proteinase K (PROT.) in the absence or
presence of Triton X-100 (DET.). Western blot analysis was done
with an antibody against Ape1p or CPY as a vacuolar marker.
B: Wild-type or vssaII cells were spheroplasted, di¡erentially lysed
and fractionated on a Ficoll gradient. The top fraction of the gra-
dient containing cytoplasm (CYT.), a fraction containing vacuoles
(VAC.) and the pellet of the gradient containing unlysed sphero-
plasts and prevacuolar vesicles (PT.) were collected. C: Upper
panel: Optiprep gradient of vssaII cell lysate (CE) and the inter-
phases of the gradient analyzed by anti-Ape1p Western blot. Lower
panel: vssaII cell lysate (CE) and vacuolar fraction (Vac.) of the Fi-
coll gradient and the Optiprep gradient centrifugation of the vacuo-
lar Ficoll gradient fraction. Western blot analyses were done for
Ape1p or for the vacuolar marker CPY and hexokinase as a cyto-
plasmic marker.
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3.2. Aminopeptidase 1 accumulates in the vssa mutants in its
dodecameric form in a prevacuolar compartment
Ape1p is synthesized as a monomer that rapidly oligomer-
izes into a pre-dodecamer [34]. To determine the oligomeriza-
tion state of the accumulated precursor, seen in the vssa mu-
tants, protein extracts from the wt and the vssaII strain grown
to mid-exponential phase were prepared and proteins were
separated according to their molecular weight on glycerol
density gradients. The gradients were fractionated, the pro-
teins in each fraction were TCA-precipitated and separated
by SDS^PAGE, and Western blot analysis was performed
using anti-Ape1p antibodies (Fig. 3). The mature dodecamer
in the wt and the vssaII strains migrated to a density corre-
sponding to a molecular weight of about 600 kDa. In the
absence of Ssa2p the precursor accumulated in the same frac-
tions as the mApe1p (Fig. 3) suggesting that the precursor was
already assembled in its dodecameric form of about 730 kDa.
To determine whether the pApe1p accumulates inside a
membrane-surrounded compartment or in the cytoplasm
[37], spheroplasts of the vssaII strain were di¡erentially lysed
to disrupt the plasma membrane, but allowing the majority of
vacuoles and Cvt vesicles to remain intact [27,29]. Protease
protection experiments with these lysed spheroplasts indicated
that the accumulating precursor in the vssaII mutant is pro-
tease-protected unless detergent was added, suggesting that it
is surrounded by a membrane (Fig. 4A). CPY, a resident
vacuolar protein, is not degraded under those conditions.
To investigate whether the precursor accumulates within the
vacuole or Cvt vesicles, subcellular fractionation experiments
using discontinuous Optiprep and Ficoll gradients were per-
formed [37]. On Ficoll gradients mApe1p was found in the
vacuolar fraction (0/4% Ficoll) of the gradient in wt cell ly-
sates as well as in vssaII cell lysates, together with the vacuo-
lar CPY. pApe1p of the vssaII strain was found in the pellet
fraction of the gradient, which is in agreement with data in
the literature (Fig. 4B). We also detected pApe1p in the va-
cuolar fraction in the vssaII strain (Fig. 4B) and to verify this
cofractionation we performed Optiprep gradient centrifuga-
tions (Fig. 4C, upper panel). The 0^19% interphase contained
the vacuoles and the 30^37% Optiprep interphase contained
the Cvt vesicles. No pellet was formed during the centrifuga-
tion. This is also in accordance with previous data, where
mApe1p was detected in the 0^19% interphase containing
the vacuoles and pApe1p in the 30^37% interphase [37].
This demonstrates that pApe1p accumulates in a prevacuolar
compartment in the vssaII strain. Trace amounts of pApe1p
corresponding to 5% of the total were found in the 0^19%
interphase. To verify whether this fraction is associated with
the vacuole we also loaded the 0^4% Ficoll interface, contain-
ing vacuoles and mApe1p as well as minor amounts of
pApe1p on top of an Optiprep gradient [37]. mApe1p and
pApe1p were not separated on the Optiprep gradient demon-
strating association of 5% pApe1p with the vacuolar fraction
(Fig. 4C, lower panel).
3.3. Ssa1/2p are localized to the vacuolar membrane in vivo
The function of Ssaps in pApe1p transport could lead to a
concentration of Ssaps at the vacuolar membrane. To test this
we performed immuno£uorescence microscopy of the strains
with an anti-Ssa1/2p antiserum (Fig. 5). Vacuolar membranes
of wt cells showed a prominent labeling of the vacuolar mem-
brane exceeding the expected strong cytoplasmic signal,
whereas vssaI/II cells did not show any membrane labeling.
Ssa3/4p can functionally replace Ssa1/2p for pApe1p import.
Therefore we wanted to know whether we could detect a
similar vacuolar staining for Ssa3/4p. When probing cells de-
leted for SSAI/SSAII with antiserum recognizing Ssa3/4p, we
noticed a much weaker overall immuno£uorescence signal
than in the case of Ssa1/2p. This re£ected the much lower
expression level of Ssa3/4p. Occasionally, but not in all cells,
we observed a staining of the vacuolar membrane that was
elevated over the cytoplasmic stain (data not shown). This
may re£ect limitations of the detection procedure or may in-
dicate the failure of Ssa3/4p to get enriched at the vacuolar
membrane well above the cytoplasmic concentration. How-
ever, Ssa2p and/or Ssa1p clearly accumulate at the vacuolar
membrane in situ. We do not know on which face(s) of the
vacuolar membrane Ssa1/2p are localized. Attempts to resolve
this question by immunoelectron microscopy did not yield
clear results (data not shown).
Fig. 5. Subcellular localization of Ssa1/2p. Upper panel: Immuno-
localization of Ssa2p in vssa1 cells, of Ssa1/2p in wt cells. Cells de¢-
cient in both proteins served as anti-Ssa1/2p antibody control. Low-
er panel: Nomarski images of the cells.
Fig. 6. Autophagocytosis can overcome the e¡ect of Ssap deletion.
Cell extracts were prepared from wt (lane 1) and vssaII strains
grown in YPD to an OD600 of 0.8 (lane 2), from vssaII strains
grown in YPD to an OD600 of 2.0 (lane 3) or grown in nitrogen
starvation medium (SD-N) to an OD600 of 0.8 (lane 4). The proteins
were separated by SDS^PAGE and western blotting was done using
antibodies against Ape1p, CPY, Ssa1/2p and Ssa3/4p.
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3.4. Autophagocytosis can overcome the e¡ect of Ssap deletion
pApe1p has been detected in small Cvt vesicles as well as
large autophagocytosis-like vesicles formed under starvation
conditions. Could it be that the induction of autophagy by
starvation can overcome the Ssap requirement of the pApe1p
targeting? Ssa3/4p expression levels are reduced under starva-
tion conditions [15]. The Ssa3/4p expression level in vssaII
under nitrogen starvation is as high as in the vssaII strain
at 30‡C, which is insu⁄cient to overcome the Ssa1/2p require-
ment for pApe1p transport (Fig. 6, lane 3, Fig. 2B, lane 3 and
Fig. 2C). Also under starvation conditions after growth in
rich medium Ssa3/4p expression levels are lower than in
vssaI/II at 30‡C, where Ssa3/4p expression levels do not re-
store pApe1p transport to the vacuole (Fig. 2A, lane 4, Fig.
2B, lane 3, Fig. 1, lanes 4 and 8). pApe1p transport under
starvation conditions would therefore occur independently of
Ssa3/4p.
Cell extracts were prepared from wt (Fig. 6, lane 1) and
vssaII strains grown in rich medium to mid-exponential phase
(Fig. 6, lane 2). To induce autophagocytosis vssaII cells were
grown to stationary phase (Fig. 6, lane 3) or grown in nitro-
gen starvation medium to mid-exponential phase (Fig. 6, lane
4). Under both starvation conditions no pApe1p accumula-
tion was observed (Fig. 6, compare lanes 3 and 4 with lane 1),
suggesting that autophagocytosis can overcome the Ssap re-
quirement and that the Ssaps are speci¢cally required in the
Cvt pathway of pApe1p transport and not in other pathways
as autophagocytosis.
4. Discussion
Using vssa strains we found that cytoplasmic Hsp70 pro-
teins are involved in the transport of pApe1p from the cyto-
plasm into the vacuole in yeast. As already known from other
Ssap-dependent processes members of the Ssa protein family
displayed overlapping functions and the overall amount of
Ssa proteins is responsible for the severity of an observed
phenotype. The accumulated precursor pApe1p forms a do-
decameric complex that can be found inside a vesicle. The
vssa mutants behave like some Cvt and autophagocytosis
mutants. As far as we know, it has never been reported that
Cvt or autophagocytosis mutants are allelic with vssa mu-
tants.
In the Cvt model suggested by Kim and co-workers [34] the
precursor obtains its dodecameric form already in the cyto-
plasm and is then taken up into an autophagosome-like
vesicle which is transported into the vacuole by macroauto-
phagocytosis. Inside the vacuole the vesicle is degraded and
the maturation of pApe1p takes place. In this model Ssa pro-
teins could target, according to their known functions,
pApe1p precursor to a forming autophagocytotic vesicle,
where they might also assist in the assembly of the pre-do-
decamer, which is ¢nally packed in these vesicles.
However, the data presented in this article suggest an alter-
native view. If the cell is depleted of cytoplasmic Hsp70s
pApe1p accumulates in autophagosome-like Cvt vesicles.
The transport and uptake of these vesicles into the vacuole
is the rate-limiting step in pApe1p transport along the Cvt
pathway in wt cells, because pApe1p can only be found in
cytoplasmic Cvt vesicles under steady state and identi¢cation
of other transport intermediates requires mutations of the
precursor pApe1p itself or of the vacuolar hydrolases which
degrade the vacuolar autophagic bodies [29]. The precursor
accumulates in these vesicles in the ssa mutants. Thus Ssaps
seem to be required for the fusion of Cvt vesicles with the
vacuole. The mechanism of Cvt vesicle to vacuole fusion is
not known. Studies on the homotypic vacuole fusion reaction
have shown that formation of multimeric NSF, SNARE-con-
taining protein complexes on the membranes required for
docking and fusion, is supported by chaperones [38]. One
may therefore speculate that Ssa1/2p are involved in the for-
mation of such protein complexes required for Cvt vesicle to
vacuole fusion. Vam3p is a vacuolar t-SNARE required for
vacuolar membrane fusion with structures from the secretory
pathway as well as the autophagocytotic pathway [39]. This
indicates that the Cvt vesicle to vacuole membrane fusion
reaction might use the same mechanisms as the homotypic
vacuolar membrane fusion reaction. However, no Hsp70 in-
volvement has been demonstrated in these reactions so far and
the vacuolar CPY is found in its mature form in the vacuole
of Ssap mutants. Formation of large protein complexes spe-
ci¢c for autophagosome to vacuole fusion has also been de-
scribed. Apg proteins form protein complexes required for
autophagocytosis in yeast and mammals [40,41]. Apg12p
and Apg5p are covalently linked by Apg10p. Apg10p is ho-
mologous to the E1 enzymes of the ubiquitin system. The
Apg12p/Apg5p complex interacts with Apg16p to form a mul-
timeric protein complex, but their role in the fusion process is
not known [42]. Our results seem to rule out a participation of
Ssaps in the fusion of autophagocytic vesicles with the vacu-
ole.
The localization of the Ssa1/2p on the vacuolar membrane
supports a function of these proteins in the Cvt vesicle to
vacuole fusion reaction. Establishing an in vitro system for
Cvt vesicle to vacuole membrane fusion will allow us to study
the function of Ssa1/2p in the Cvt vesicle to vacuole fusion
reaction.
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